clomipramine (Q58713)

clomipramine (English)

17 November 2016

chemical formula

C₁₉H₂₃ClN₂

1 reference

clomipramine (English)

17 November 2016

canonical SMILES

CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl

1 reference

World Health Organisation international non-proprietary name

clomipramine (English)

17 November 2016

1 reference

14 February 2018

clomipramine (English)

IPA transcription

kloʊˈmɪpɹəmin

2 references

Clomipramine (English)

medical condition treated

19 January 2016

published in

Recommended INN: List 7

publication date

1967

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

obsessive-compulsive disorder

13 December 2016

2 references

13 December 2016

Drug Indications Extracted from FAERS

obsessive-compulsive disorder

2 October 2018

start time

29 December 1989

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/NUV44L116D

http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019906s039lbl.pdf

significant drug interaction

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-nefopam

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

delirium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

xerostomia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Sleep state misperception

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irritability

1 reference

A reference set of clinically relevant adverse drug-drug interactions

delirium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 6 member 3

1 reference

Potassium inwardly-rectifying channel, subfamily J, member 6

17 August 2016

1 reference

Potassium inwardly-rectifying channel, subfamily J, member 5

17 August 2016

1 reference

Solute carrier family 6 member 2

17 August 2016

1 reference

solute carrier family 6 member 4

17 August 2016

1 reference

Australian pregnancy category C

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Clomipramine

last update

15 October 2017

selective serotonin reuptake inhibitor

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D002997

adrenergic uptake inhibitors

15 March 2018

1 reference

5 March 2018

tricyclic antidepressant

1 reference

Food and Drug Administration

Medical Subject Headings

15 March 2018

0 references

clomiPRAMINE

subject named as

Clomipramine

1 reference

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3

2 September 2022

Commons category

Clomipramine

0 references

Identifiers

InChI

1 reference

clomipramine (English)

17 November 2016

2 references

clomipramine (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

303-49-1

2 references

clomipramine (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=303-49-1

10 April 2021

1 reference

Clomipramine (English)

17 November 2016

2 references

clomipramine (English)

17 November 2016

Reaxys registry number

1323477

1 reference

clomipramine (English)

19 October 2016

ChEBI ID

47780

mapping relation type

2 references

CLOMIPRAMINE (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3

1 reference

CLOMIPRAMINE (English)

17 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU152706

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA000980

0 references

MSBNK-Waters-WA000981

0 references

MSBNK-Waters-WA000982

0 references

MSBNK-Waters-WA000983

0 references

MSBNK-Waters-WA000984

0 references

SPLASH

splash10-014i-2009000000-a1cc70dad4bb4c19ab7b

0 references

splash10-000i-9000000000-a9af3369f8d6da434fd0

0 references

splash10-052r-9000000000-3f1941447bc096ea9d73

0 references

splash10-0a4r-9010000000-c6b5c5a56ac456cd8845

0 references

splash10-0a4i-9010000000-8b5307526ea875a06881

0 references

splash10-0a4i-9010000000-98746d4db184914ce871

0 references

splash10-0a4i-9310000000-194486cca11709cd1b80

0 references

splash10-0a4i-9600000000-da861dd5252aaff30e89

0 references

splash10-0a4i-6900000000-efdead8e50e8b700d4bd

0 references

splash10-00di-0090000000-c95496c45b925520559b

0 references

splash10-00di-0090000000-0f4826359eaf958cf3f9

0 references

splash10-014i-0009002000-5d404f398b1424000228

0 references

splash10-014i-0009000000-ee8c700208fb6d810d7f

0 references

splash10-066r-6391000000-e57dc447a97807ce527a

0 references

HSDB ID

7746

1 reference

Hazardous Substances Data Bank

28 October 2019

Clomipramine (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

clomipramine (English)

ECHA Substance Infocard ID

17 November 2016

100.005.587

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.005.587

27 December 2018

Clomipramine (English)

quotation

CAS no.: 303-49-1 (English)

1 reference

World Health Organisation international non-proprietary name numeric ID

Clomipramine (English)

publication date

17 November 2015

2238

1 reference

https://mednet-communities.net/inn/db/ViewINN.aspx?i=2238

1 reference

clomipramine (English)

17 November 2016

Clomipramine

0 references

0 references

0 references

1 reference

clomipramine (English)

17 November 2016

DrugBank ID

DB01242

1 reference

Human Metabolome Database ID

HMDB0015372

2 references

based on heuristic

inferred from InChIKey

2 references

clomipramine (English)

17 November 2016

MedlinePlus drug identifier

0 references

1 reference

clomipramine (English)

17 November 2016

0 references

1 reference

1 reference

b093c05d-fe2d-4ec1-850d-f5a6056fbb9a

clomipramine (English)

19 October 2016

0 references

1 reference

electronic Essential Medicines List medicine ID

BBC Things

249

1 reference

https://list.essentialmeds.org/medicines/249

eEML - Electronic Essential Medicines List (English)

Encyclopædia Britannica Online ID

23 October 2021

science/clomipramine

subject named as

clomipramine

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

2QEI (English)

19 October 2016

1 reference

2Q6H (English)

19 October 2016

1 reference

imported from Wikimedia project

4MMA (English)

19 October 2016

1 reference

1 reference

clomipramine (English)

17 November 2016

0 references

0 references

WordNet 3.1 Synset ID

03052307-n

1 reference